Alendronate may raise risk of irregular heat beat

NEW YORK (Reuters Health) - Women who have ever used alendronate, also known by the trade name Fosamax, may have an increased risk of atrial fibrillation, according to findings from a new study. However, the overall risk is low and is likely outweighed by the benefits of fracture prevention in patients with osteoporosis if they have no ot...

Continue to Alendronate may raise risk of irregular heat beat on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz